Publications by authors named "Louis Coupal"

Claim this Profile
R
Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).
Denis Choquette, Dafna D Gladman, Robert D Inman, Proton Rahman, Marie-Claude Laliberté, Louis Coupal

J Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical Eczema Associated With Biologic Therapy in Psoriasis: A Systematic Review and Meta-Analysis.
Maharshi Gandhi, Gazal Javed, Catherine Zhu, Katya Peri, Connor Prosty, Louis Coupal

J Cutan Med Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA.
Denis Choquette, Boulos Haraoui, Mohammad Movahedi, Louis Bessette, Loïc Choquette Sauvageau, Louis Coupal

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Analysis of Weather Variation on Disease Activity and Patient-Reported Outcomes in Psoriatic Arthritis.
Maxine Joly-Chevrier, Louis Coupal, Loïc Choquette Sauvageau, Mohammad Movahedi, Denis Choquette

J Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anti-rheumatic treatment on the individual components of the ACR composite score in patients with rheumatoid arthritis: real-world data.
Mohammad Movahedi, Denis Choquette, Louis Coupal, Edward Keystone, Claire Bombardier

Clin Exp Rheumatol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
Dafna D Gladman, Vinod Chandran, Cheryl F Rosen, Sherry Rohekar, Tristan Boyd, Louis Coupal

J Rheumatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of tofacitinib and TNF inhibitors in patients with rheumatoid arthritis: analysis of pooled data from two registries in Canada.
Mohammad Movahedi, Denis Choquette, Louis Coupal, Angela Cesta, Xiuying Li

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.
Glen S Hazlewood, Claire Bombardier, Xiuying Li, Mohammad Movahedi, Denis Choquette, Louis Coupal

J Rheumatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis.
Elena Lopatina, Deborah A Marshall, Louis Coupal, Jacques Le Lorier, Denis Choquette

Curr Med Res Opin· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry.
Denis Choquette, Louis Bessette, Evo Alemao, Boulos Haraoui, Roelien Postema, Louis Coupal

Arthritis Res Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomagnesemia During Teriparatide Treatment in Osteoporosis: Incidence and Determinants.
Marie-Josée Bégin, Louis-Georges Ste-Marie, Louis Coupal, Jean Ethier, Agnès Räkel

J Bone Miner Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer.
Peter Blume-Jensen, David M Berman, David L Rimm, Michail Shipitsin, Mathew Putzi, Louis Coupal

Clin Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the benefits of patient and physician adherence to cardiovascular prevention guidelines: the MyHealthCheckup Survey.
Steven Grover, Louis Coupal, Mohammed Kouache, Ilka Lowensteyn, Sylvie Marchand

Can J Cardiol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, Mohammed Kaouache, Sylvie Marchand, Louis Coupal

J Gen Intern Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?
Steven Grover, Louis Coupal, Ilka Lowensteyn

Can J Cardiol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the cost-effectiveness of preventing cardiovascular disease: are estimates calculated over the duration of a clinical trial adequate?
Steven A Grover, Louis Coupal, Ilka Lowensteyn

Can J Cardiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the cost effectiveness of ramipril used for specific clinical indications: comparing the outcomes in four clinical trials with a common economic model.
Steven A Grover, Louis Coupal, Ilka Lowensteyn

Am J Cardiovasc Drugs· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial.
Steven A Grover, Ilka Lowensteyn, Lawrence Joseph, Mohammed Kaouache, Sylvie Marchand, Louis Coupal

Arch Intern Med· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing cardiovascular disease among Canadians: what are the potential benefits of treating hypertension or dyslipidemia?
Steven A Grover, Louis Coupal, Mohammed Kaouache, Ilka Lowensteyn

Can J Cardiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial?
Steven Grover, Ilka Lowensteyn, David Hajek, John Trachtenberg, Louis Coupal

J Urol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
Steven A Grover, Ilka Lowensteyn, Mohammed Kaouache, Sylvie Marchand, Louis Coupal

Arch Intern Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of lipid-lowering treatment according to lipid level.
Louise Pilote, Vivian Ho, Frédéric Lavoie, Louis Coupal, Hanna Zowall

Can J Cardiol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy.
Steven A Grover, Louis Coupal, Norbert Gilmore, Jayanti Mukherjee

Am J Cardiol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?
Steven A Grover, Louis Coupal, Hanna Zowall

Hypertension· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor.
Steven A Grover, Louis Coupal, Hanna Zowall, Thomas W Weiss, Charles M Alexander

Am J Med· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis